Novo Ventures 1 A/S

Novo Ventures 1 A/S

Novo Ventures 1 A/S

Date Founded



Tuborg Havnevej 19,Hellerup, Capital Region 2900

Type of Company


Employees (Worldwide)

11 - 50


Private Equity & Venture Capital
Accounting & Financial Services
Investment Services & Portfolio Management

Company Description

Novo Ventures is an active manager which provides funding for early and later-stage capital requirements, and provides management support. The firm invests in both public and private companies from Northern Europe and the United States. Novo Ventures targets companies operating in the health technology and health services sector, and industries such as biotechnology and medical specialties. It looks to take minority stake positions in its investments, as well as a seat on the board.

Contact Data
Trying to get in touch with decision makers at Novo Ventures 1 A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Managing Partner

Senior Partner

Senior Partner

Senior Partner

Venture Partner



Senior Principal

Asset Director

Paths to Novo Ventures 1 A/S
Potential Connections via
Relationship Science
Novo Ventures 1 A/S
Recent Transactions
Details Hidden

Anokion SA purchases Kanyos Bio, Inc. from Versant Venture Management LLC, Novartis Venture Fund, Astellas Venture Management LLC, Novo Ventures 1 A/S

Details Hidden

Pfizer, Inc. purchases TherAchon SAS from Sofimac Innovation SAS, New Enterprise Associates, Pfizer Venture Investments, Versant Venture Management LLC, BPIFrance Investissement SAS, OrbiMed Advisors Private Equity, Novo Ventures 1 A/S, Triartisan Capital Advisors LLC

Details Hidden

Smith & Nephew Plc purchases Ceterix Orthopaedics, Inc. from Versant Venture Management LLC, 5AM Venture Management LLC, Novo Ventures 1 A/S

Advisors & Consultants
Legal Advisor

Partner at Wilson Sonsini Goodrich & Rosati PC

Details Hidden

Aristea Therapeutics, Inc. operates as a clinical-stage drug development company. It develops novel therapies to treat serious inflammatory diseases. The company was founded by James Morrison MacKay in 2018 and is headquartered in Poway, CA.

Details Hidden

Cyteir Therapeutics, Inc. engages in the development of novel therapeutics and deoxyribonucleic acid repair and synthetic lethal therapies. It exploits the synthetic lethality of gain-of-function DNA-damaging genes and DNA repair inhibition, resulting in selective death among cells. The company was founded by Kevin Mills and Timothy Romberger and is headquartered in Lexington, MA.

Details Hidden

Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Novo Ventures 1 A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Novo Ventures 1 A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Novo Ventures 1 A/S.